Search
for
Sort by
Research 91–120 of 300
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Hair Loss in Children, Etiologies, and Treatment
- 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats
- Cyclosporine-Induced Alopecia in Childhood Nephrotic Syndrome – A Case Report
- Adverse Cutaneous Reactions to Antidepressants
- Postmenopausal Alopecia (Hair Loss)
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Trichotillomania
- Depression, anxiety and perceived stress in women with and without PCOS: a community-based study
- Psychodermatology
- Dopamine is a novel, direct inducer of catagen in human scalp hair follicles<i>in vitro</i>
- Tales of bugs, delusions of parasitosis, and what to do
- The Skin and Subcutaneous Tissues
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Pediatric Psychocutaneous Disorders
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- New lifestyle drugs and somatoform disorders in dermatology
- HAIR LOSS: CAUSES AND PATHOLOGY
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- The Neurobiology of Sexual Function
- Midazolam Inhibits Hippocampal Long-Term Potentiation and Learning through Dual Central and Peripheral Benzodiazepine Receptor Activation and Neurosteroidogenesis
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Psychodermatology
- A double-blind, placebo-controlled study of inositol in trichotillomania
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Telogen Effluvium
- Current and future pharmacotherapy for alopecia areata